These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27808105)

  • 1. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
    Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
    Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
    Yang S; Jia R; Bian Z
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SRSF3 is Correlated with Carcinogenesis and Progression of Oral Squamous Cell Carcinoma.
    Peiqi L; Zhaozhong G; Yaotian Y; Jun J; Jihua G; Rong J
    Int J Med Sci; 2016; 13(7):533-9. PubMed ID: 27429590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
    Sun Y; Yan L; Guo J; Shao J; Jia R
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation.
    Yu C; Guo J; Liu Y; Jia J; Jia R; Fan M
    J Cell Physiol; 2015 Sep; 230(9):2252-61. PubMed ID: 25752295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
    Guo J; Jia J; Jia R
    Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
    Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
    Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma.
    Su W; Tang J; Wang Y; Sun S; Shen Y; Yang H
    J Cell Mol Med; 2019 Apr; 23(4):2645-2655. PubMed ID: 30677230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.
    Jia R; Che X; Jia J; Guo J
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.
    Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y
    Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis.
    More DA; Singh N; Mishra R; Muralidharan HP; Gopinath KS; Gopal C; Kumar A
    PLoS One; 2024; 19(5):e0296565. PubMed ID: 38781195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m
    Wang X; Zhi M; Zhao W; Deng J
    IUBMB Life; 2024 Jul; 76(7):437-450. PubMed ID: 38265150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
    Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
    Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
    Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
    RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.